Jeroen Jwm Janssen

5PUBLICATIONS
47CO-AUTHORS
Haematological tumoursMedical bacteriologyEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 16, 2026
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

|Aug 08, 2024
Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity.

Nick A de Jonge, Jeroen J W M Janssen, Paula Ypma

|Jul 10, 2024
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.

Fabio Efficace, Francois-Xavier Mahon, Johan Richter

|Jul 22, 2022
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

J J W M Janssen, B Löwenberg, M Manz

|May 16, 2020
The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach.

Geneviève Icg Ector, Peter E Westerweel, Rosella Pmg Hermens

Pageof 1

Frequent Collaborators

2 joint publications

Peter E Westerweel

2 joint publications

Nicole Ma Blijlevens

2 joint publications

Andreas Hochhaus

1 joint publications

M Manz